Ramipres H Tablet (10 Tab)

About Ramipres H Tablet:

Ramipres H Tablet is a combination medication, indicated to manage high blood pressure.

Each uncoated Ramipres H Tablet contains Ramipril 2.5 mg and Hydrochlorothiazide 12.5 mg.

Ramipril and Hydrochlorothiazide both are antihypertensive class of medication.

Ramipril belongs to a class of ACE (Angiotensin-converting enzyme) inhibitors and acts by inhibiting the angiotensin-converting enzyme. It relaxes the blood vessels, thereby, reducing the blood pressure.

Hydrochlorothiazide belongs to a class of thiazide diuretic medicines. It acts by increasing the production of more urine to excrete excess fluid and certain electrolytes from the body. In this way, it lowers high blood pressure.

Use of Ramipres H Tablet:

Ramipres H Tablet is prescribed for the management of hypertension (high blood pressure).

Usage Direction of Ramipres H Tablet:

• Ramipres H Tablet is intended for oral use only, in a dose and direction as prescribed by the physician.
• Ramipres H Tablet is taken whole with the help of water.
• Do not crush, chew or break the tablet.
• Do not skip or stop the medicine without the physician’s advice.
• Do not consume more than the prescribed quantity.

Precaution & Related information of Ramipres H Tablet:

• If hypersensitive or allergic to Ramipres H Tablet, inform the physician immediately.  
• Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor.
• Ramipril can cause symptomatic hypotension, after either the initial dose or a later dose when the dosage has been increased.
• In patients with congestive heart failure, with or without associated renal insufficiency, ACE inhibitor therapy may cause excessive hypotension, which may be associated with oliguria or azotemia and, rarely, with acute renal failure and death. In such patients, ramipril therapy should be started under close medical supervision.
• Take precautions in case of heart failure Post-Myocardial Infarction, hypersensitivity reaction, hyperkalemia, hypokalemia, hyponatremia & hypochloremic alkalosis, hypercalcemia, hypomagnesemia.
• Persistent non-productive cough has been reported with all ACE inhibitors always resolving after discontinuation of therapy.
• The antihypertensive effects of hydrochlorothiazide may be enhanced in the post-sympathectomy patient.
• Thiazide diuretics have been reported to cause exacerbation or activation of systemic lupus erythematosus.
• Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. Untreated acute angle-closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.
• Thiazide therapy may impair glucose tolerance, whereas hypoglycemia may occur in diabetic patients under insulin or anti-diabetic therapy and telmisartan treatment. Therefore, in these patients blood glucose monitoring should be considered; a dose adjustment of insulin or antidiabetics may be required, when indicated.
• Discontinue Ramipril if the patient develops jaundice or marked elevations of hepatic enzymes.
• If found any other complications, inform the physician immediately.
• The physician should be aware of the concomitant use of Ramipres H Tablet with any other medication.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.

Storage condition of Ramipres H Tablet:

Store in a cool, dry place.